| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |